The pre-operative assessment of bronchial carcinoma. The surgeon's viewpoint;Le bilan préopératoire du cancer bronchique. Le point de vue du chirurgien

Revue des Maladies Respiratoires

Volumn 22, Issue 4, 2005, Pages 635-650

  Decker, G ^a,b   De Leyn, P ^a  

^a CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^b Hopital Universitaire de Leuven   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; DIAGNOSTIC ACCURACY; ENDOSCOPIC BIOPSY; HISTOPATHOLOGY; HUMAN; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MEDIASTINOSCOPY; MEDIASTINUM; MEDICAL DECISION MAKING; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; SURGEON; SURGICAL RISK; THORACOSCOPY;

EID: 25844502593     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1019/200530066     Document Type: Review

References (97)

1. Rusch V: Evidence-based outcomes for patients with NSCLC undergoing resection. Seminars in Respiratory and Critical Care Medicine 2000; 21: 433-41.
2. Pearson FG, Deslauriers J, Ginsberg RJ, Hiebert CA, McKneally MF, Urschel HC: In: Thoracic Surgery. Churchill Livingstone 1995; 671-705.
3. Carbone PP, Frost JK, Feinstein AR, Higgins GA, Selawry OS: Lung cancer: perspective and prospects. Ann Intern Med 1970; 73: 1003-24.
4. Harpole LH, Kelley MJ, Schreiber G, Toloza EM, Kolimaga J, McCrory DC: Assessment of the scope and quality of clinical practice guidelines in lung cancer. Chest 2003; 123: 7S-20S.
5. Kormas P, Bradshaw JR, Jeyasingham K: Preoperative computed tomography of the brain in non-small cell bronchogenic carcinoma. Thorax 1992; 47: 106-8.
6. Yung RC: Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration and resectional biopsy. Respir Care Clin NAm 2003; 9: 51-76.
7. American Thoracic Society/European Respiratory Society: Pretreatment Evaluation of Non-Small-cell Lung Cancer. Am J Respir Crit Care Med 1997; 156: 320-32.
8. Mountain CF, Dresler CM: Regional lymph node classification for lung cancer staging. Chest 1997; 111: 1718-23.
9. Naruke T, Suemasu K, Ishikawa S: Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Surg 1978; 76: 832-7.
10. Lung cancer. In: Sobin LH, Wittekind C: TNM classification of malignant tumours. UICC Sixth edition 2002; 98-103.
11. Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A, Mate JL, Li S, Roig J, Olazabal A: A randomized trial comparing pre-operative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994; 330: 153-8.
12. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS, DhiNSngra H, De Caro L, Chasen M, McGavran M: A randomized trial comparing preoperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994; 86: 673-80.
13. Lorent N, De Leyn P, Lievens Y, Verbeken E, Nackaerts K, Dooms C, Van Raemdonck D, Anrys B, Vansteenkiste J, Leuven Lung Cancer Group: Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience. Ann Oncol 2004; 15: 1645-53.
14. Beckles MA, Spiro SG, Colice GL, Rudd RM: Initial evaluation of the patients with lung cancer. Symptoms, signs, laboratory tests and paraneoplastic syndromes. Chest 2003; 123: 97S-104S.
15. Guyatt GH, Cook DJ, Griffith LE, Miller JD, Todd TRJ, Johnston MR, Winton TL, Casson AG, Inculet RI, Darling GE, Finley RJ, Deslauriers J and the Canadian Lung Oncology Group: Surgeon's assessment of symptoms suggesting extrathoracic metastases in patients with lung cancer. Ann Thorac Surg 1999; 68: 309-15.
16. Bréchot JM, Morère JF: Diagnostic et bilan d'extension du cancer bronchique. Rev Mal Respir 2004; 21: 168-70.
17. British Thoracic Society and Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party: Guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56: 89-108.
18. Tsang GMK, Watson DCT: The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer. Thorax 1992; 47: 3-5.
19. Goldstraw P: The practice of cardiothoracic surgeons in the perioperative staging of non-small cell cancer. Thorax 1992; 47: 1-2.
20. Martini N, Flehinger BJ: The role of surgery in N2 lung cancer. Surg Clin North Am 1987; 67: 1037-49.
21. Naruke T, Goya T, Tsuchiya R, Suemasu K: The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg 1988; 46: 603-10.
22. Choi YS, Shim YM, Jhingook K, Kim K: Mediastinoscopy in patients with clinical stage I non-small cell lung cancer. Ann Thor Surg 2003; 75: 364-6.
23. De Leyn P, Vansteenkiste J, Cuypers P, Deneffe G, Van Raemdonck D, Coosemans W, Verschakelen J, Lerut T: Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg 1997; 12: 706-12.
24. Fernando HC, Goldstraw P: The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging. Cancer 1990; 65: 2503-6.
25. Patterson GA, Piazza D, Pearson FG, Todd TRJ, Ginsberg RJ, Goldberg M, Waters P, Jones D, Ilves R, Cooper JD: Significance of metastatic disease in subaortic lymph nodes. Ann Thor Surg 1987; 43: 155-9.
26. Keller SM, Vangel MG, Wagner H, Schiller JH, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH, Eastern Cooperative Oncology Group: Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thor Cardiovasc Surg 2004; 128: 130-7.
27. Toloza EM, Harpole L, McCrory DC: Noninvasive staging of non-small cell lung cancer. A review of current evidence. Chest 2003; 123: 137S-146S.
28. Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Brochhagen HG, Schneider PM, Hölscher AH: Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 2003; 123: 463-7.
29. Dillemans B, Deneffe G, Verschakelen J, Decramer M: Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. A study of 569 patients. Eur J Cardiothorac Surg 1994; 8: 37-42.
30. Watanabe Y, Shimizu J, Oda M, Hayashi Y, Tatsuzawa Y, Watanabe S, Yoshida M, Iwa T: Improved survival in left non-small-cell N2 lung cancer after more extensive operative procedure. Thorac Cardiovasc Surg 1991; 39: 89-94.
31. Kramer H, Groen HJM: Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer. Ann Surg 2003; 238: 180-8.
32. Eloubeidi MA, Cerfolio RJ, Chen VK, Desmond R, Syed S, Ojha B: Endoscopic ultrasound-guided fin needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans. Ann Thor Surg 2005; 79: 263-8.
33. Dujon C, Barbieux H, Maunoury V, Godchaux JM, Lafitte JJ, Marquette CH: Diagnostic d'adénopathies médiastinales par échoendoscopie trans-oesophagienne. Rev Mal Respir 2003; 20: 41-9.
34. Passlick B: Initial surgical staging of lung cancer. Lung Cancer 2003; 42: S21-S25.
35. Park BJ, Flores R, Downey RJ, Bains MS, Rusch VW: Management of major hemorrhage during mediastinoscopy. J Thorac Cardiovasc Surg 2003; 126: 726-31.
36. Luke WP, Pearson FG, Todd TR, Patterson GA, Cooper JD: Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg 1986; 91: 53-6.
37. Toloza EM, Harpole L, Detterbeck F, McCrory DC: Invasive staging of non-small cell lung cancer. A review of current evidence. Chest 2003; 123: 157S-66S.
38. Martin-Ucar AE, Chetty GK, Vaughan R, Waller DA: A prospective audit evaluating the role of videoassisted cervical mediastinoscopyas a training tool. Eur J Cardiothorac Surg 2004; 26: 393-5.
39. Leschber G, Holinka G, Linder A: Video-assisted mediastinoscopic lymphadenectomy (VAMLA) - a method for systematic lymphnode dissection. Eur J Cardiothorac Surg 2003; 24: 192-5.
40. Hillers TK, Sauve MD, Guyatt GH: Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer. Thorax 1994; 49: 14-9.
41. Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F: The noninvasive staging of non-small cell lung cancer. The guidelines. Chest 2003; 123: 147S-156S.
42. The Canadian Lung Oncology Group: Investigating extrathoracic metastatic disease in patients with apparently operable lung cancer. Ann Thor Surg 2001; 71: 425-34.
43. Grant D, Edwards D, Goldstraw P: Computed tomography of brain, chest and abdomen in the preoperative assessment of non-small cell lung cancer. Thorax 1988; 43: 883-6.
44. Davis PC, Hudgins PA, Peterman SB, Hoffman JC: Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. Am J Neuroradiol 1991; 12: 293-300.
45. Vansteenkiste JF, Stroobants SG: The role of positron emission tomography with 18F-fluoro-2-deoxy-d-glucose in respiratory oncology. Eur Respir J 2001; 17: 802-20.
46. Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK: Test performance of Positron Emission Tomography and Computed Tomography for mediastinal staging in patients with non-small-cell Lung Cancer. Ann Intern Med 2003; 139: 879-92.
47. Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K: Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. Chest 1997; 112: 416-22.
48. Detterbeck FC, Falen S, Rivera P, Halle JS, Socinski MA: Seeking a Home for a PET, Part 1. Chest 2004; 125: 2294-9.
49. Stroobants SG, D'Hoore I, Dooms C, De Leyn PR, Dupont PJ, De Wever W, De Groot T, Verschakelen JA, Mortelmans LA, Vansteenkiste JF: Additional value of whole-body fluorodeoxyglucose positron emission tomography in the detection of distant metastases of non-small cell lung cancer. Clin Lung Cancer 2003; 4: 242-7.
50. Weder W, Schmid RA, Bruchhaus H, Hillinger S, von Schulthess GK, Steinen HC: Detection of extra-thoracic métastases by positron emission tomography in lung cancer. Ann Thor Surg 1998; 66: 886-93.
51. Reed CE, Harpole DH, Posther KE, Woolson SL, Downey RJ, Meyers BF, Heelan RT, MacApinlac HA, Jung S, Silvestri GA, Siegel BA, Rusch VW: Results of the American College of Surgeons Oncology Group Z00050 Trial: The utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thor Cardiovasc Surg 2003; 126: 1943-51.
52. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL: Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s - Meta-analytic Comparison of PET and CT. Radiology 1999; 213: 530-6.
53. Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, De Wever WF, Verbeken EK, Nuyts JL, Maes FP, Bogeart JG and the Leuven Lung Cancer Group: FDG-PET-scan in potentially operable non-small cell lung cancer: do anatomometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? Eur J Nucl Med 1998; 25: 1495-501.
54. Van Tinteren H, Hoekstra OS, Smit EF, Van den Bergh JHA, Schreurs AJM, Stallaert RA, Van Velthoven PCM, Comans EFI, Diepenhorst FW, Verboom P, Van Mourik JC, Postmus PE, Boers M, Teule GJJ and the PLUS study group: Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002; 359: 1388-92.
55. Viney RC, Boyer MJ, King MT, Kenny PM, Pollicino CA, McLean JM, McCaughan BC, Fulham MJ: Randomized controlled trial of the role of Positron Emission Tomography in the management of stage I and II non-small-cell lung cancer. J Clin Oncol 2004; 22: 2357-62.
56. Detterbeck FC, Falen S, Rivera P, Halle JS, Socinski MA: Seeking a Home for a PET, Part 2. Chest 2004; 125: 2300-8.
57. Sugarbaker DJ, Strauss GM: Advances in Surgical Staging and Therapy of Non-small-cell Lung Cancer. Seminars in Oncology 1993; 2: 163-172.
58. Van Schil P: The restaging issue. Lung Cancer 2003; 42: S39-S45.
59. Vansteenkiste J, Stroobants S, Hoekstra C, Smit E, Van Zandwijk N, Schramel F, Biesma B, Nackaerts K, Van Raemdonck D, Lammerstma A, Mortelmans M: Fluoro-deoxyglucose positron emission tomography in the assessment of induction chemotherapy in stage IIIa-N2 NSCLC: a multicenter prospective study. Proc ASCO 2001; 20: 1250.
60. Akhurst T, Downey RJ, Ginsberg MS, Gonen M, Bains M, Korst R, Ginsberg RJ, Rusch VW, Larson SM: An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg 2002; 73: 259-66.
61. Van Schil P, Van der Schoot, Poniewierski J, Pauwels M, Carp L, Germonpré P, De Backer W: Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer. Lung Cancer 2002; 37: 281-5.
62. Meersschaut D, Vermassen F, Brutel de la Rivière A, Knaepen PJ, Van den Bosch JM, Vanderschueren R: Repeat mediastinoscopy in the assessment of new and recurrent lung neoplasm. Ann Thorac Surg 1992; 53: 120-2.
63. Bueno R, Richards WG, Swanson SJ, Jaklitsch MT, Lukanich JM, Mentzer SJ, Sugarbaker DJ: Nodal stage after induction chemotherapy for stage IIA lung cancer determines patient survival. Ann Thorac Surg 2000; 70: 1826-31.
64. Brutsche MH, Spiliopoulos A, Bolliger CT, Licker M, Frey JG, Tschopp JM: Exercise capacity and extent of resection as predictors of surgical risk in lung cancer. Eur Respir J 2000; 15: 828-32.
65. Loddenkemper R, Gabler A, Göbel D: Criteria of functional operability in patients with bronchial carcinoma. Preoperative assessment of risk and prediction of postoperative function. Thorac Cardiovasc Surg 1983; 31: 334-7.
66. Beckles MA, Spiro SG, Colice GL, Rudd RM: The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest 2003; 123: 105S-114S.
67. Licker M, de Perrot M, Hohn L, Schopp JM, Robert J, Frey JG, Schweizer A, Spiliopoulos A: Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma. Eur J Cardiothorac Surg 1999; 15: 314-9.
68. Damhuis RAM, Schütte PR: Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J 1996; 9: 7-10.
69. Bernard A, Deschamps C, Allen MS, Miller DL, Trastek VF, Jenkins GD, Pairolero PC: Pneumonectomy for malignant disease: Factors affecting early morbidity. J Thorac Cardiovasc Surg 2001; 121: 1076-82.
70. Deslauriers J, Gregoire J, Jacques LF, Piraux M, Guojin L, Lacasse Y: Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences. Ann Thorac Surg 2004; 77: 1152-6.
71. Smetana GW: Preoperative pulmonary evaluation. New Engl J Med 1999; 340: 937-44.
72. Bolliger CT, Perruchoud AP: Functional evaluation of the lung resection candidate. Eur Respir J 1998; 11: 198-212.
73. Markos J, Mullan BP, Hillman DR, Musk AW, Antico VF, Lovegrove FT, Carter MJ, Finucane KE: Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 1989; 139: 902-10.
74. Ferguson MK, Little L, Rizzo L, Popovich KJ, Glonek GF, Leff A, Manjoney D, Little AG: Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg 1988; 96: 894-900.
75. Bolliger CT, Soler M, Stulz P, Grädel E, Müller-Brand J, Elsasser S, Gonon M, Wyser C, Perruchoud AP: Evaluation of high-risk lung resection candidates: Pulmonary haemodynamics versus exercise testing. Respiration 1994; 61: 181-6.
76. Win T, Laroche CM, Groves AM, White C, Wells FC, Ritchie AJ, Tasker AD: Use of quantitative lung scintigraphy to predict postoperative pulmonary function in lung cancer patients undergoing lobectomy. Ann Thorac Surg 2004; 78: 1215-8.
77. Wyser C, Stulz P, Soler M, Tamm M, Muller-Brand J, Habicht J, Perruchoud AP, Bolliger CT: Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am J Respir Crit Care Med 1999; 159: 1450-6.
78. Eagle KA, Brundage BH, Chairman BR, Ewy GA, Fleisher LA, Hertzer NR, Leppo JA, Ryan T, Schlant RC, Spencer WH 3rd, Spittell JA Jr, Twiss RD, Ritchie JL, Cheitlin MD, Gardner TJ, Garson A Jr, Lewis RP, Gibbons RJ, O'Rourke RA, Ryan TJ: Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 1996; 27: 910-48.
79. Olsen GN: Lung Cancer resection. Who's inoperable? Chest 1995; 108: 298-9.
80. Sioris T, Salo J, Perhoniemi V, Manila S: Surgery for lung cancer in the elderly. Scand Cardiovasc J 1999; 33: 222-7.
81. Port JL, Kent M, Korst RJ, Lee PC, Levin MA, Flieder D, Altorki NK: Surgical resection for lung cancer in the octogenarian. Chest 2004; 126: 733-8.
82. McKenna RJ, Fischel RJ, Brenner M, Gelb AF: Combined operations for lung volume reduction surgery and lung cancer. Chest 1996; 110: 885-8.
83. Warren WH, Faber LP: Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma: five-year survival and patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg 1994; 107: 1087.
84. Morice RC, Peters EJ, Ryan MB, Putnam JB, Ali MK, Roth JA: Exercise testing in the evaluation of patients at high risk of complications from lung resection. Chest 1992; 101: 356-61.
85. Kearney DJ, Lee TH, Reilly JJ, DeCamp MM, Sugarbaker DJ: Assessment of operative risk in patients undergoing lung resection: importance of predicted pulmonary function. Chest 1994; 105: 753-9.
86. Ribas J, Diaz O, Barbera JA, Mateu M, Canalis E, Jover L, Roca J, Rodriguez-Roisin R: Invasive exercise testing in the evaluation of patients at high-risk for lung resection. Eur Respir J 1998; 12: 1429-35.
87. Pate P, Tenholder MF, Griffin JP, Eastridge CE, Weiman DS: Preoperative assessment of the high-risk patient for lung resection. Ann Thor Surg 1996; 61: 1494-500.
88. Varela G, Jimenez MF, Novoa N, Macri P: Discordance between predicted postoperative forced expiratory volumes in one second (ppoFEV1) calculated before and after resection of bronchogenic carcinoma. Interact Cardiovascul Thorac Surg 2003; 2: 138-42.
89. Leo F, Solli P, Spaggiari L, Veronesi G, de Braud F, Leon ME, Pastorino U: Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications. Ann Thorac Surg 2004; 77: 260-5.
90. Warner MA, Offord KP, Warner ME, Lennon RL, Conover MA, Janson-Schumacher U: Role of Preoperative Cessation of Smoking and Other Factors in Post-operative Pulmonary complications: A Blinded Prospective Study of Coronary Artery Bypass Patients. Mayo Clin Proc 1989; 64: 609-16.
91. Yamashita S, Yamaguchi H, Sakaguchi M, Yamamoto S, Aoki K, Shiga, Hisajima Y: Effect of smoking cessation on intraoperative sputum and postoperative pulmonary complications in minor surgical patients. Respir Med 2004; 98; 760-6.
92. Vaporciyan AA, Merriman KW, Ece F, Roth JA, Smythe WR, Swisher S, Walsh GL, Nesbitt JC, Puttnam JB Jr: Incidence of major pulmonary morbidity after pneumonectomy in association with timing of smoking cessation. Ann Thor Surg 2002; 73: 420-6.
93. Sorensen LT, Jorgensen T: Short-term pre-operative smoking cessation intervention does not affect postoperative complications in colorectal surgery: a randomized clinical trial. Colorect Dis 2003; 5: 347-52.
94. Knott-Craig CJ, Howell CE, Parsons BD, Paulsen SM, Brown BR, Elkins RC: Improved results in the management of surgical candidates with lung cancer. Ann Thorac Surg 1997; 63: 1405-10.
95. Berrisford RG, Sabenathan SS, Mearns AJ, Bickford-Smith PJ: Pulmonary complications of lung resection: the effect of continous extra-pleural intercostal nerve block. Eur J Cardiothorac Surg 1990; 4: 407-11.
96. Asimakopoulos G, Al-Ruzzeh S, Ambler G, Omar RZ, Punjabi P, Amrani M, Taylor KM: An evaluation of existing risk stratification models as a tool for comparison of surgical performances for coronary artery bypass grafting between institutions. Eur J Cardiothorac Surg 2003; 23: 935-42.
97. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II. A severity of disease classification system. Crit Care Med 1985; 13: 818-23.